Pick Topic
Review Topic
List Experts
Examine Expert
Save Expert
  Site Guide ··   
Expertise in Psoriasis: HELP
Melinda J. Gooderham
Based on 37 articles published since 2009
(Why 37 articles?)
||||
Expertise Level
The expertise of Melinda J. Gooderham ranks in the
  • Top 0.16%
  • ... of 37,586 published authors worldwide on Psoriasis
  • ... from 2009 through 2019
  • ... based on contributions to 37 articles on the topic.
Graphical view (beta)
Get your prestigious
Expert badge
similar to this:
 
Aliases Gooderham, Melinda J   ·   Gooderham, M   ·   Gooderham, Melinda   ·   Gooderham, M J
Work Locations
Details
Most likely:    Queen's University      
2019
  • Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf and Skinflammation Center, Hamburg, Germany. Electronic address: · School of Medicine, Queen's University, Kingston, Ontario, Canada; Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada. · Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, CA, USA. · Charles Institute of Dermatology, University College Dublin, Ireland. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USA. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. · AbbVie Inc, North Chicago, IL, USA. · AbbVie Inc, Redwood City, CA, USA. · Paul Sabatier University and Larrey Hospital, Toulouse, France. · Pubmed 31280967
2018
  • McMaster University, Faculty of Health Sciences, Hamilton, ON, Canada; University of Toronto, Faculty of Medicine, Toronto, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON Canada; Queen's University, Kingston, ON Canada. · Probity Medical Research, Waterloo, ON Canada; K Papp Clinical Research, Waterloo, ON Canada. · Pubmed 29562088
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo (K.P.), the SKiN Centre for Dermatology and Probity Medical Research, Peterborough (M.G.), and Queen's University, Kingston (M.G.) - all in Ontario, Canada · Medical College of Wisconsin, Milwaukee (K.G.) · the University of Luebeck, Luebeck, Germany (D.T.) · Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (A.M.) · the University of Melbourne, St. Vincent's Hospital Melbourne, Skin and Cancer Foundation, and Probity Medical Research, Melbourne, VIC, Australia (P.F.) · and Bristol-Myers Squibb, Princeton, NJ (I.G.G., S.K., S.B.). · Pubmed 30205746
  • 1 Dermatrials Research, Inc, Hamilton, ON, Canada. · 2 Venderm Innovations in Psoriasis, Hamilton, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Queens University, Kingston, ON, Canada. · 5 Guenther Dermatology Research Centre, London, ON, Canada. · 6 Western University, London, ON, Canada. · 7 Clinique de Dermatologie Protoderma, Montréal, QC, Canada. · 8 Division of Dermatology, University of Alberta, Edmonton, AB, Canada. · 9 LEO Pharma Inc Canada, Thornhill, ON, Canada. · 10 SCRIPT, Toronto, ON, Canada. · Pubmed 29754528
  • University of Connecticut Health Center, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Queen's University, Kingston, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada. · Radboud University Medical Center and Radboud University, Nijmegen, The Netherlands. · Beth Israel Deaconess Hospital and Harvard Medical School, Boston, Massachusetts. · Dalhousie University, Halifax, Nova Scotia, Canada. · Medical College of Wisconsin, Milwaukee, Wisconsin. · Janssen Scientific Affairs, LLC, Horsham, Pennsylvania. · Janssen Research & Development, LLC, Spring House, Pennsylvania. · Baylor University Medical Center at Dallas, Dallas, Texas. · Pubmed 29102053
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
  • Dermatrials Research, Hamilton, ON, Canada. · McMaster University, Hamilton, ON, Canada. · SKiN Centre for Dermatology, Peterborough, ON, Canada. · Queens University, Kingston, ON, Canada. · Guenther Dermatology Research Centre, London, ON, Canada. · University of Western Ontario, London, ON, Canada. · Clinique de Dermatologie Protoderma, Montreal, QC, Canada. · Division of Dermatology, University of Alberta Medical School, Edmonton, AB, Canada. · LEO Pharma Inc., Thornhill, ON, Canada. · SCRIPT, Toronto, ON, Canada. · Pubmed 29633366
2017
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada · Oregon Medical Research Center, Portland (A.B.) · Altman Dermatology Associates, Arlington Heights, IL (M.B.) · Rockefeller University, New York (J.K.) · Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.) · Baylor Research Institute, Dallas (A.M.) · Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany · University of Texas Health Science Center, Houston (S.T.) · University of California, Los Angeles, School of Medicine, Los Angeles (H.S.) · and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.). · Pubmed 28423301
  • 1 Université de Montreal, Montreal, QC, Canada. · 2 Université de Sherbrooke, Quebec, QC, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 University of British Columbia, Surrey, BC, Canada. · 5 Memorial University of Newfoundland, St John's, NL, Canada. · 6 University of Toronto, Toronto, ON, Canada. · 7 Université de Laval, Quebec, QC, Canada. · 8 McMaster University, Hamilton, ON, Canada. · 9 University of Manitoba, Winnipeg, MB, Canada. · Pubmed 29156950
  • 1 University of Manitoba Faculty of Health Sciences, College of Medicine, Winnipeg, MB, Canada. · 2 Queen's University, Kingston, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27846617
2016
  • K Papp Clinical Research and Probity Medical Research Inc, Waterloo, ON, Canada. · Innovaderm Research, Montreal, QC, Canada. · SKiN Centre for Dermatology and Probity Medical Research Inc, Peterborough, and Queens University, Kingston, ON, Canada. · Wake Forest Baptist Health, Winston-Salem, NC, USA. · Aarhus University Hospital, Aarhus, Denmark. · Southern California Dermatology, Santa Ana, CA, USA. · Dermatology Consulting Services, High Point, NC, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pubmed 27716172
2017
  • From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · Pubmed 28604347
Probable:    Miscellaneous cities in Ontario      
2018
  • SKiN Centre for Dermatology, Probity Medical Research, Queen's University, Peterborough, ON, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Lynde Dermatology, Probity Medical Research, Markham, ON, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 29438576
  • Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · The McGovern School of Medicine of the University of Texas, Houston, Texas; Brain Health Consultants, Houston, Texas. · University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California. · Oregon Medical Research Center, Portland, Oregon. · Skin Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey. · Dow Pharmaceutical (a division of Valeant Pharmaceuticals North America LLC), Petaluma, California. · Pubmed 28985956
  • Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · SKiN Centre for Dermatology, Queen's University and Probity Medical Research, Peterborough, Ontario, Canada. · Whipps Cross University Hospital, London, UK. · The Royal London Hospital, London, UK. · George Washington University, School of Medicine, Washington, DC, USA. · Southern California Dermatology, Santa Ana, CA, USA. · Celgene Corporation, Summit, NJ, USA. · Cardiff University and University Hospital of Wales, Wales, UK. · Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada. · Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29220542
  • 1 Dermatrials Research, Inc, Hamilton, ON, Canada. · 2 Venderm Innovations in Psoriasis, Hamilton, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Queens University, Kingston, ON, Canada. · 5 Guenther Dermatology Research Centre, London, ON, Canada. · 6 Western University, London, ON, Canada. · 7 Clinique de Dermatologie Protoderma, Montréal, QC, Canada. · 8 Division of Dermatology, University of Alberta, Edmonton, AB, Canada. · 9 LEO Pharma Inc Canada, Thornhill, ON, Canada. · 10 SCRIPT, Toronto, ON, Canada. · Pubmed 29754528
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
  • Innovaderm Research, Montreal, QC, Canada. · Winnipeg Clinic, Winnipeg, MB, Canada. · North Bay Dermatology Centre, North Bay, ON, Canada. · Lynderm Research, Markham, ON, Canada. · Altman Dermatology Associates, Arlington Heights, IL, USA. · Dermatology Specialists Research, Louisville, KY, USA. · Dr Isabelle Delorme Inc., Drummondville, QC, Canada. · Dre Angélique Gagné-Henley MD Inc., Saint-Jérôme, QC, Canada. · Dr. Melinda Gooderham SKiN Centre for Dermatology, Peterborough, ON, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Québec, QC, Canada. · Kirk Barber Research, Calgary, AB, Canada. · Dermatology Associates, Seattle, WA, USA. · Nexus Clinical Research, St. John's, NL, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Pubmed 29055155
  • Dermatrials Research, Hamilton, ON, Canada. · McMaster University, Hamilton, ON, Canada. · SKiN Centre for Dermatology, Peterborough, ON, Canada. · Queens University, Kingston, ON, Canada. · Guenther Dermatology Research Centre, London, ON, Canada. · University of Western Ontario, London, ON, Canada. · Clinique de Dermatologie Protoderma, Montreal, QC, Canada. · Division of Dermatology, University of Alberta Medical School, Edmonton, AB, Canada. · LEO Pharma Inc., Thornhill, ON, Canada. · SCRIPT, Toronto, ON, Canada. · Pubmed 29633366
2017
  • Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France. · Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy. · Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia. · Skin & Cancer Foundation Inc., Carlton, Australia. · Probity Medical Research, Carlton, Australia. · SKiN Centre for Dermatology, ON, Canada. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Veracity Clinical Research, Woolloongabba, Queensland, Australia. · Probity Medical Research, Woolloongabba, Queensland, Australia. · University of Connecticut Health Center, Farmington, CT, U.S.A. · Probity Medical Research, Farmington, CT, U.S.A. · Pubmed 28755394
  • Probity Medical Research Inc., Waterloo, ON, Canada. · Skin Center for Dermatology, Probity Medical Research Inc., Queen's University, Peterborough, ON, Canada. · DIEX Recherche Sherbrooke, Sherbrooke, QC, Canada. · The Center for Dermatology and Probity Medical Research Inc., Richmond Hill, ON, Canada. · Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA. · Pubmed 28556418
  • SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. · SKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada. · George Washington University School of Medicine, Washington, DC, USA. · Whipps Cross University Hospital & the Royal London Hospital, London, UK. · Celgene Corporation, Summit, NJ, USA. · Cardiff University and University Hospital of Wales, Wales, UK. · Southern California Dermatology, Santa Ana, CA, USA. · Pubmed 27768242
  • 1 University of Manitoba Faculty of Health Sciences, College of Medicine, Winnipeg, MB, Canada. · 2 Queen's University, Kingston, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27846617
2016
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Skin Center for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Clinica Dermacross, Santiago, Chile. · Pfizer Inc, Collegeville, Pennsylvania. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, New York, New York. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 27692733
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · SKiN Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint-Louis, Paris, France. · Celgene Corporation, Warren, New Jersey. · Bakersfield Dermatology, Bakersfield, California. · Pubmed 26549249
  • Skin Centre for Dermatology, Peterborough, Ontario, Canada · Amgen Canada Inc, Mississauga, Ontario, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 26330052
  • Baylor University Medical Center, Dallas, TX, USA. · K Papp Clinical Research and Probity Medical Research, Inc., Waterloo, Ontario, Canada. · SKIN Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Eastern Virginia Medical School and Virginia Clinical Research, Norfolk, VA, USA. · University Medical Center, Hamburg-Eppendorf, Hamburg, Germany. · Florida Academic Dermatology Centers, Miami, FL, USA. · Janssen Scientific Affairs, LLC, Horsham, PA, USA. · Janssen Research & Development, LLC, Horsham, PA, USA. · Janssen Research & Development, LLC, Titusville, NJ, USA. · Janssen-Cilag NV, Beerse, Belgium. · University of Utah School of Medicine, Salt Lake City, UT, USA. · Pubmed 27027388
2015
  • Department of Dermatology, Toulouse University, Hôpital Larrey, 24 Chemin de Pouvourville, Toulouse, 31000, France. · Modern Research Associates, Dallas, TX, U.S.A. · Skin Centre for Dermatology, Peterborough, ON, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Québec, QC, Canada. · Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · University Hospital Germans Trias i Pujol, Badalona, Spain. · Universidad Autónoma of Barcelona, Barcelona, Spain. · Bakersfield Dermatology, Bakersfield, CA, U.S.A. · Celgene Corporation, Warren, NJ, U.S.A. · University of Verona, Verona, Italy. · Tufts Medical Center, Boston, MA, U.S.A. · Pubmed 26357944
2014
  • SKiN Centre for Dermatology, 743 Lansdowne Street West, Peterborough, ON, Canada, K9J 1Z. · Pubmed 24980277
2013
Probable:    Miscellaneous institutions in Waterloo      
2018
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
2017
  • University of Toronto, Faculty of Medicine, Toronto, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 28486717
  • Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France. · Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy. · Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia. · Skin & Cancer Foundation Inc., Carlton, Australia. · Probity Medical Research, Carlton, Australia. · SKiN Centre for Dermatology, ON, Canada. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Veracity Clinical Research, Woolloongabba, Queensland, Australia. · Probity Medical Research, Woolloongabba, Queensland, Australia. · University of Connecticut Health Center, Farmington, CT, U.S.A. · Probity Medical Research, Farmington, CT, U.S.A. · Pubmed 28755394
  • K Papp Clinical Research, Waterloo, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, Assistance Publique-Hopitaux de Paris Saint-Louis Hospital, Paris, France. · Dermatology Unit, Department of Neuroscience, Mental Health and Sensory Systems (NeSMOS) Department, Sapienza University of Rome, Rome, Italy. · Probity Medical Research, Carlton, Australia; Department of Medicine (Dermatology), University of Melbourne, St Vincent's Hospital Melbourne, Skin and Cancer Foundation Inc, Melbourne, Australia. · Probity Medical Research, Waterloo, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada. · Amgen Inc, Thousand Oaks, California. · Dermoklinika Medical Centre, Lodz, Poland. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Probity Medical Research, Woolloongabba, Australia; Veracity Clinical Research, Woolloongabba, Australia. · Regional Hospital, Department of Dermatology, Wroclaw, Poland. · Probity Medical Research, Farmington, Connecticut; University of Connecticut Health Center, Connecticut. · Pubmed 28291552
  • 1 University of Manitoba Faculty of Health Sciences, College of Medicine, Winnipeg, MB, Canada. · 2 Queen's University, Kingston, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27846617
2016
  • Skin Centre for Dermatology, Peterborough, ON, Canada Probity Medical Research, Waterloo, ON, Canada · Skin Centre for Dermatology, Peterborough, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27207348
2015
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26382906
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Division of Dermatology, University of Toronto, Toronto, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 25807214
Show More
Specific Interests

In the titles of their published articles, experts often reveal their very specific interests.

Here are the titles of the 10 most recent articles (out of 37 total) written by Melinda J. Gooderham about Psoriasis:

  • Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial. 2019
  • Brodalumab: A Review of Safety. 2018
  • Shifting the focus - the primary role of IL-23 in psoriasis and other inflammatory disorders. 2018
  • Clinical Trial and Registry Data. 2018
  • Psychiatric adverse events during treatment with brodalumab: Analysis of psoriasis clinical trials. 2018
  • Phase 2 Trial of Selective Tyrosine Kinase 2 Inhibition in Psoriasis. 2018
  • Safety and efficacy of apremilast through 104 weeks in patients with moderate to severe psoriasis who continued on apremilast or switched from etanercept treatment: findings from the LIBERATE study. 2018
  • Canadian Patients' Preferences in Topical Psoriasis Care: Insights From the PROPEL Surveys. 2018
  • Depressive symptoms, depression, and the effect of biologic therapy among patients in Psoriasis Longitudinal Assessment and Registry (PSOLAR). 2018
  • Persistency of Biologic Therapies for Plaque Psoriasis in 2 Large Community Practices. 2018
Show List of Full Article Records
Google Searches

Learn more about Melinda J. Gooderham using the ready-made Google searches below.
This is essential! -- Publications never tell the whole story!

General Search:
Queen's University
Miscellaneous cities in Ontario
Miscellaneous institutions in Waterloo
Affiliation Timeline
Click for institutional directory in table below. (Not always available.)
What is this?
Queen's University
2019
  • Translational Research in Inflammatory Skin Diseases, Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf and Skinflammation Center, Hamburg, Germany. Electronic address: · School of Medicine, Queen's University, Kingston, Ontario, Canada; Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada. · Institute and Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Bakersfield Dermatology and Skin Cancer Medical Group, Bakersfield, CA, USA. · Charles Institute of Dermatology, University College Dublin, Ireland. · Laboratory for Investigative Dermatology, The Rockefeller University, New York, NY, USA. · National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. · Boehringer Ingelheim Pharmaceuticals Inc, Ridgefield, CT, USA. · AbbVie Inc, North Chicago, IL, USA. · AbbVie Inc, Redwood City, CA, USA. · Paul Sabatier University and Larrey Hospital, Toulouse, France. · Pubmed 31280967
2018
  • McMaster University, Faculty of Health Sciences, Hamilton, ON, Canada; University of Toronto, Faculty of Medicine, Toronto, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON Canada; Queen's University, Kingston, ON Canada. · Probity Medical Research, Waterloo, ON Canada; K Papp Clinical Research, Waterloo, ON Canada. · Pubmed 29562088
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo (K.P.), the SKiN Centre for Dermatology and Probity Medical Research, Peterborough (M.G.), and Queen's University, Kingston (M.G.) - all in Ontario, Canada · Medical College of Wisconsin, Milwaukee (K.G.) · the University of Luebeck, Luebeck, Germany (D.T.) · Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan (A.M.) · the University of Melbourne, St. Vincent's Hospital Melbourne, Skin and Cancer Foundation, and Probity Medical Research, Melbourne, VIC, Australia (P.F.) · and Bristol-Myers Squibb, Princeton, NJ (I.G.G., S.K., S.B.). · Pubmed 30205746
  • 1 Dermatrials Research, Inc, Hamilton, ON, Canada. · 2 Venderm Innovations in Psoriasis, Hamilton, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Queens University, Kingston, ON, Canada. · 5 Guenther Dermatology Research Centre, London, ON, Canada. · 6 Western University, London, ON, Canada. · 7 Clinique de Dermatologie Protoderma, Montréal, QC, Canada. · 8 Division of Dermatology, University of Alberta, Edmonton, AB, Canada. · 9 LEO Pharma Inc Canada, Thornhill, ON, Canada. · 10 SCRIPT, Toronto, ON, Canada. · Pubmed 29754528
  • University of Connecticut Health Center, Farmington, Connecticut; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Queen's University, Kingston, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada. · Radboud University Medical Center and Radboud University, Nijmegen, The Netherlands. · Beth Israel Deaconess Hospital and Harvard Medical School, Boston, Massachusetts. · Dalhousie University, Halifax, Nova Scotia, Canada. · Medical College of Wisconsin, Milwaukee, Wisconsin. · Janssen Scientific Affairs, LLC, Horsham, Pennsylvania. · Janssen Research & Development, LLC, Spring House, Pennsylvania. · Baylor University Medical Center at Dallas, Dallas, Texas. · Pubmed 29102053
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
  • Dermatrials Research, Hamilton, ON, Canada. · McMaster University, Hamilton, ON, Canada. · SKiN Centre for Dermatology, Peterborough, ON, Canada. · Queens University, Kingston, ON, Canada. · Guenther Dermatology Research Centre, London, ON, Canada. · University of Western Ontario, London, ON, Canada. · Clinique de Dermatologie Protoderma, Montreal, QC, Canada. · Division of Dermatology, University of Alberta Medical School, Edmonton, AB, Canada. · LEO Pharma Inc., Thornhill, ON, Canada. · SCRIPT, Toronto, ON, Canada. · Pubmed 29633366
2017
  • From K. Papp Clinical Research and Probity Medical Research, Waterloo, ON (K.A.P.), School of Medicine, Queen's University, Kingston, ON (M.G.), and Centre for Dermatology and Probity Medical Research, Peterborough, ON (M.G.) - all in Canada · Oregon Medical Research Center, Portland (A.B.) · Altman Dermatology Associates, Arlington Heights, IL (M.B.) · Rockefeller University, New York (J.K.) · Hôpital de l'Archet, University of Nice-Sophia Antipolis, Nice, France (J.-P.L.) · Baylor Research Institute, Dallas (A.M.) · Charité Universitätsmedizin Berlin, Berlin (S.P.), Boehringer Ingelheim Pharma, Biberach (B.R.B.), and Boehringer Ingelheim Pharma, Ingelheim, (S.J.P.) - all in Germany · University of Texas Health Science Center, Houston (S.T.) · University of California, Los Angeles, School of Medicine, Los Angeles (H.S.) · and Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT (S.V., C.P., N.B., M.F., P.S.). · Pubmed 28423301
  • 1 Université de Montreal, Montreal, QC, Canada. · 2 Université de Sherbrooke, Quebec, QC, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 University of British Columbia, Surrey, BC, Canada. · 5 Memorial University of Newfoundland, St John's, NL, Canada. · 6 University of Toronto, Toronto, ON, Canada. · 7 Université de Laval, Quebec, QC, Canada. · 8 McMaster University, Hamilton, ON, Canada. · 9 University of Manitoba, Winnipeg, MB, Canada. · Pubmed 29156950
  • 1 University of Manitoba Faculty of Health Sciences, College of Medicine, Winnipeg, MB, Canada. · 2 Queen's University, Kingston, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27846617
2016
  • K Papp Clinical Research and Probity Medical Research Inc, Waterloo, ON, Canada. · Innovaderm Research, Montreal, QC, Canada. · SKiN Centre for Dermatology and Probity Medical Research Inc, Peterborough, and Queens University, Kingston, ON, Canada. · Wake Forest Baptist Health, Winston-Salem, NC, USA. · Aarhus University Hospital, Aarhus, Denmark. · Southern California Dermatology, Santa Ana, CA, USA. · Dermatology Consulting Services, High Point, NC, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pfizer Worldwide Biopharmaceuticals, Global Innovative Pharma Business, Groton, CT, USA. · Pubmed 27716172
2017
  • From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · From the University of Toronto, Toronto, Ontario; Université Laval, Quebec, Quebec; Queen's University, Kingston; University of Ottawa, Ottawa; Western University, London; Dermatrials Research, Inc., Hamilton, Ontario; Université de Montréal, Montreal; Université de Sherbrooke, Sherbrooke, Quebec; The Winnipeg Clinic, Winnipeg, Manitoba; University of Calgary, Calgary; University of Alberta, Edmonton, Alberta; University of British Columbia, Vancouver, British Columbia; Memorial University of Newfoundland, St. John's, Newfoundland, Canada. · D.D. Gladman, MD, FRCPC, Professor of Medicine, University of Toronto; Y. Poulin, MD, Université Laval; K. Adams, MD, Université Laval; M. Bourcier, MD, Université de Sherbrooke; S. Barac, MD, The Winnipeg Clinic; K. Barber, MD, University of Calgary; V. Chandran, MBBS, MD, DM, PhD, University of Toronto; J. Dutz, MD, University of British Columbia; C. Flanagan, MD, University of British Columbia; M.J. Gooderham, MD, Queen's University; W.P. Gulliver, MD, Memorial University of Newfoundland; V.C. Ho, MD, University of British Columbia; C.H. Hong, MD, University of British Columbia; J. Karsh, MD, University of Ottawa; M.M. Khraishi, MBBCH, Memorial University of Newfoundland; C.W. Lynde, MD, University of Toronto; K.A. Papp, MD, PhD, University of Toronto; P. Rahman, MD, Memorial University of Newfoundland; S. Rohekar, MD, Western University; C.F. Rosen, MD, University of Toronto; A.S. Russell, MD, University of Alberta; R.B. Vender, MD, Dermatrials Research, Inc.; J. Yeung, MD, University of Toronto; O. Ziouzina, MD, University of Calgary; M. Zummer, MD, Université de Montréal. · Pubmed 28604347
Miscellaneous cities in Ontario
2018
  • SKiN Centre for Dermatology, Probity Medical Research, Queen's University, Peterborough, ON, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, ON, Canada. · Lynde Dermatology, Probity Medical Research, Markham, ON, Canada. · Department of Medicine, University of Toronto, Toronto, ON, Canada. · Pubmed 29438576
  • Icahn School of Medicine at Mount Sinai, New York, New York. Electronic address: · K. Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · The McGovern School of Medicine of the University of Texas, Houston, Texas; Brain Health Consultants, Houston, Texas. · University of California San Francisco Psoriasis and Skin Treatment Center, San Francisco, California. · Oregon Medical Research Center, Portland, Oregon. · Skin Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Kaiser Permanente Los Angeles Medical Center, Los Angeles, California. · Valeant Pharmaceuticals North America LLC, Bridgewater, New Jersey. · Dow Pharmaceutical (a division of Valeant Pharmaceuticals North America LLC), Petaluma, California. · Pubmed 28985956
  • Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · SKiN Centre for Dermatology, Queen's University and Probity Medical Research, Peterborough, Ontario, Canada. · Whipps Cross University Hospital, London, UK. · The Royal London Hospital, London, UK. · George Washington University, School of Medicine, Washington, DC, USA. · Southern California Dermatology, Santa Ana, CA, USA. · Celgene Corporation, Summit, NJ, USA. · Cardiff University and University Hospital of Wales, Wales, UK. · Division of Dermatology, Women's College Hospital, Toronto, Ontario, Canada. · Division of Dermatology, Department of Medicine, University of Toronto, Toronto, Ontario, Canada. · Pubmed 29220542
  • 1 Dermatrials Research, Inc, Hamilton, ON, Canada. · 2 Venderm Innovations in Psoriasis, Hamilton, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Queens University, Kingston, ON, Canada. · 5 Guenther Dermatology Research Centre, London, ON, Canada. · 6 Western University, London, ON, Canada. · 7 Clinique de Dermatologie Protoderma, Montréal, QC, Canada. · 8 Division of Dermatology, University of Alberta, Edmonton, AB, Canada. · 9 LEO Pharma Inc Canada, Thornhill, ON, Canada. · 10 SCRIPT, Toronto, ON, Canada. · Pubmed 29754528
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
  • Innovaderm Research, Montreal, QC, Canada. · Winnipeg Clinic, Winnipeg, MB, Canada. · North Bay Dermatology Centre, North Bay, ON, Canada. · Lynderm Research, Markham, ON, Canada. · Altman Dermatology Associates, Arlington Heights, IL, USA. · Dermatology Specialists Research, Louisville, KY, USA. · Dr Isabelle Delorme Inc., Drummondville, QC, Canada. · Dre Angélique Gagné-Henley MD Inc., Saint-Jérôme, QC, Canada. · Dr. Melinda Gooderham SKiN Centre for Dermatology, Peterborough, ON, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Québec, QC, Canada. · Kirk Barber Research, Calgary, AB, Canada. · Dermatology Associates, Seattle, WA, USA. · Nexus Clinical Research, St. John's, NL, Canada. · Department of Dermatology, Eastern Virginia Medical School and Virginia Clinical Research Inc., Norfolk, VA, USA. · Pubmed 29055155
  • Dermatrials Research, Hamilton, ON, Canada. · McMaster University, Hamilton, ON, Canada. · SKiN Centre for Dermatology, Peterborough, ON, Canada. · Queens University, Kingston, ON, Canada. · Guenther Dermatology Research Centre, London, ON, Canada. · University of Western Ontario, London, ON, Canada. · Clinique de Dermatologie Protoderma, Montreal, QC, Canada. · Division of Dermatology, University of Alberta Medical School, Edmonton, AB, Canada. · LEO Pharma Inc., Thornhill, ON, Canada. · SCRIPT, Toronto, ON, Canada. · Pubmed 29633366
2017
  • Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France. · Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy. · Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia. · Skin & Cancer Foundation Inc., Carlton, Australia. · Probity Medical Research, Carlton, Australia. · SKiN Centre for Dermatology, ON, Canada. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Veracity Clinical Research, Woolloongabba, Queensland, Australia. · Probity Medical Research, Woolloongabba, Queensland, Australia. · University of Connecticut Health Center, Farmington, CT, U.S.A. · Probity Medical Research, Farmington, CT, U.S.A. · Pubmed 28755394
  • Probity Medical Research Inc., Waterloo, ON, Canada. · Skin Center for Dermatology, Probity Medical Research Inc., Queen's University, Peterborough, ON, Canada. · DIEX Recherche Sherbrooke, Sherbrooke, QC, Canada. · The Center for Dermatology and Probity Medical Research Inc., Richmond Hill, ON, Canada. · Kyowa Kirin Pharmaceutical Development, Inc., Princeton, NJ, USA. · Pubmed 28556418
  • SCIderm Research Institute and Dermatologikum Hamburg, Hamburg, Germany. · SKiN Centre for Dermatology and Probity Medical Research, Peterborough, ON, Canada. · George Washington University School of Medicine, Washington, DC, USA. · Whipps Cross University Hospital & the Royal London Hospital, London, UK. · Celgene Corporation, Summit, NJ, USA. · Cardiff University and University Hospital of Wales, Wales, UK. · Southern California Dermatology, Santa Ana, CA, USA. · Pubmed 27768242
  • 1 University of Manitoba Faculty of Health Sciences, College of Medicine, Winnipeg, MB, Canada. · 2 Queen's University, Kingston, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27846617
2016
  • Wake Forest University School of Medicine, Winston-Salem, North Carolina. · Comprehensive Center for Inflammation Medicine, University of Lübeck, Lübeck, Germany. · Skin Center for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Institute for Health Services Research in Dermatology and Nursing, University Medical Center Hamburg-Eppendorf, Hamburg, Germany. · Clinica Dermacross, Santiago, Chile. · Pfizer Inc, Collegeville, Pennsylvania. · Pfizer Inc, Groton, Connecticut. · Pfizer Inc, New York, New York. · Pfizer Inc, Groton, Connecticut. Electronic address: · Pubmed 27692733
  • Oregon Health and Science University, Portland, Oregon. Electronic address: · SKiN Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Sorbonne Paris Cité Université Paris Diderot, Assistance Publique-Hôpitaux de Paris Hôpital Saint-Louis, Paris, France. · Celgene Corporation, Warren, New Jersey. · Bakersfield Dermatology, Bakersfield, California. · Pubmed 26549249
  • Skin Centre for Dermatology, Peterborough, Ontario, Canada · Amgen Canada Inc, Mississauga, Ontario, Canada. · K Papp Clinical Research and Probity Medical Research, Waterloo, Ontario, Canada. · Pubmed 26330052
  • Baylor University Medical Center, Dallas, TX, USA. · K Papp Clinical Research and Probity Medical Research, Inc., Waterloo, Ontario, Canada. · SKIN Centre for Dermatology and Probity Medical Research, Peterborough, Ontario, Canada. · Eastern Virginia Medical School and Virginia Clinical Research, Norfolk, VA, USA. · University Medical Center, Hamburg-Eppendorf, Hamburg, Germany. · Florida Academic Dermatology Centers, Miami, FL, USA. · Janssen Scientific Affairs, LLC, Horsham, PA, USA. · Janssen Research & Development, LLC, Horsham, PA, USA. · Janssen Research & Development, LLC, Titusville, NJ, USA. · Janssen-Cilag NV, Beerse, Belgium. · University of Utah School of Medicine, Salt Lake City, UT, USA. · Pubmed 27027388
2015
  • Department of Dermatology, Toulouse University, Hôpital Larrey, 24 Chemin de Pouvourville, Toulouse, 31000, France. · Modern Research Associates, Dallas, TX, U.S.A. · Skin Centre for Dermatology, Peterborough, ON, Canada. · Centre de Recherche Dermatologique du Québec Métropolitain, Québec, QC, Canada. · Psoriasis Center at the Department of Dermatology, University Medical Center Schleswig-Holstein, Campus Kiel, Germany. · University Hospital Germans Trias i Pujol, Badalona, Spain. · Universidad Autónoma of Barcelona, Barcelona, Spain. · Bakersfield Dermatology, Bakersfield, CA, U.S.A. · Celgene Corporation, Warren, NJ, U.S.A. · University of Verona, Verona, Italy. · Tufts Medical Center, Boston, MA, U.S.A. · Pubmed 26357944
2014
  • SKiN Centre for Dermatology, 743 Lansdowne Street West, Peterborough, ON, Canada, K9J 1Z. · Pubmed 24980277
2013
Miscellaneous institutions in Waterloo
2018
  • 1 University of Ottawa, Ottawa, ON, Canada. · 2 University of Manitoba Rady Faculty of Health Sciences, Max Rady College of Medicine, Winnipeg, MB, Canada. · 3 Queen's University, Kingston, ON, Canada. · 4 SkiN Centre for Dermatology, Peterborough, ON, Canada. · 5 Probity Medical Research Inc., Waterloo, ON, Canada. · 6 University of Waterloo, Waterloo, ON, Canada. · 7 K. Papp Clinical Research, Waterloo, ON, Canada. · Pubmed 29056080
2017
  • University of Toronto, Faculty of Medicine, Toronto, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 28486717
  • Clinical Research, Waterloo, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, AP-HP HP Hôpital Saint-Louis, INSERM U1163, Institut Imagine, Paris, France. · Dermatology Unit, Department of Biomedical Sciences, Humanitas University, Rozzano - Milan, Italy. · Department of Medicine (Dermatology), The University of Melbourne, St Vincent's Hospital Melbourne, Australia. · Skin & Cancer Foundation Inc., Carlton, Australia. · Probity Medical Research, Carlton, Australia. · SKiN Centre for Dermatology, ON, Canada. · Amgen Inc., Thousand Oaks, CA, U.S.A. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Veracity Clinical Research, Woolloongabba, Queensland, Australia. · Probity Medical Research, Woolloongabba, Queensland, Australia. · University of Connecticut Health Center, Farmington, CT, U.S.A. · Probity Medical Research, Farmington, CT, U.S.A. · Pubmed 28755394
  • K Papp Clinical Research, Waterloo, Ontario, Canada; Probity Medical Research, Waterloo, Ontario, Canada. Electronic address: · Sorbonne Paris Cité Université Paris Diderot, Department of Dermatology, Assistance Publique-Hopitaux de Paris Saint-Louis Hospital, Paris, France. · Dermatology Unit, Department of Neuroscience, Mental Health and Sensory Systems (NeSMOS) Department, Sapienza University of Rome, Rome, Italy. · Probity Medical Research, Carlton, Australia; Department of Medicine (Dermatology), University of Melbourne, St Vincent's Hospital Melbourne, Skin and Cancer Foundation Inc, Melbourne, Australia. · Probity Medical Research, Waterloo, Ontario, Canada; SKiN Centre for Dermatology, Peterborough, Ontario, Canada. · Amgen Inc, Thousand Oaks, California. · Dermoklinika Medical Centre, Lodz, Poland. · Psoriasis Research and Treatment Center, University Hospital Charité, Berlin, Germany. · Probity Medical Research, Woolloongabba, Australia; Veracity Clinical Research, Woolloongabba, Australia. · Regional Hospital, Department of Dermatology, Wroclaw, Poland. · Probity Medical Research, Farmington, Connecticut; University of Connecticut Health Center, Connecticut. · Pubmed 28291552
  • 1 University of Manitoba Faculty of Health Sciences, College of Medicine, Winnipeg, MB, Canada. · 2 Queen's University, Kingston, ON, Canada. · 3 SKiN Centre for Dermatology, Peterborough, ON, Canada. · 4 Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27846617
2016
  • Skin Centre for Dermatology, Peterborough, ON, Canada Probity Medical Research, Waterloo, ON, Canada · Skin Centre for Dermatology, Peterborough, ON, Canada. · Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada Probity Medical Research, Waterloo, ON, Canada. · Pubmed 27207348
2015
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 26382906
  • Skin Centre for Dermatology, Peterborough, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada. · Skin Centre for Dermatology, Peterborough, ON, Canada; Division of Dermatology, University of Toronto, Toronto, ON, Canada. · K. Papp Clinical Research, Waterloo, ON, Canada; Probity Medical Research, Waterloo, ON, Canada. · Pubmed 25807214
Miscellaneous cities in Canada
2017
  • Oregon Medical Research Center, Portland, Oregon. Electronic address: · Queen's University, SKiN Centre for Dermatology, Peterborough, Canada. · Department of Dermatology, Aarhus University Hospital, Aarhus, Denmark. · Eli Lilly and Company, Indianapolis, Indiana. · Dermatologikum Hamburg and SCIderm Research Institute, Hamburg, Germany. · Pubmed 28917383
  • a Second City Outcomes Research , Chicago , IL , USA. · b Department of Medical Research , China Medical University Hospital, China Medical University , Taichung , Taiwan. · c SKIN Centre for Dermatology , Peterborough , ON , Canada. · d Eli Lilly and Company Ltd. , Windlesham , Surrey , UK. · e Lilly Deutschland GmbH , Bad Homburg , Germany. · Pubmed 27471948
2016
  • a Faculty of Medicine , University of Toronto , Toronto , Canada. · b Skin Centre for Dermatology , Peterborough , Canada. · c Probity Medical Research , Waterloo , Canada. · d K. Papp clinical Research , Waterloo , Canada. · Pubmed 27690669
10 Other Locations Show
Yearly article counts 1111274110000
 
Remember this Person You can save this page -- like a bookmark -- so it's remembered for you on the Expertscape "Saved Pages" page, which is always easily available from the page-top menu bar throughout the site.